EUVIMEDEUVIMED entdecken
Open Access

Decoding resistance in triple-negative breast cancer: NF-κB as a therapeutic target for oncolytic virotherapy

Afsar U Ahmed

Molecular Therapy · 2026-08 · 34 (8) · 4372-4373

DOI: 10.1016/j.ymthe.2026.07.007 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Therapy, 2026-08. Verfasst von Afsar U Ahmed. Beteiligte Einrichtung: Department of Microbiology, Anatomy, Physiology and Pharmacology (MAPP), School of Agriculture, Biomedicine and Environment (SABE), La Trobe Universi…. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Department of Microbiology, Anatomy, Physiology and Pharmacology (MAPP), School of Agriculture, Biomedicine and Environment (SABE), La Trobe University, Bundoora, VIC 3086, Australia; Aeterna Health Services Pty Ltd, Bi…

Zitieren

APA

Ahmed, A. U. (2026). Decoding resistance in triple-negative breast cancer: NF-κB as a therapeutic target for oncolytic virotherapy. Molecular Therapy, 34(8), 4372-4373. https://doi.org/10.1016/j.ymthe.2026.07.007

Vancouver

Ahmed AU. Decoding resistance in triple-negative breast cancer: NF-κB as a therapeutic target for oncolytic virotherapy. Molecular Therapy. 2026;34(8):4372-4373. doi:10.1016/j.ymthe.2026.07.007

BibTeX
@article{Ahmed2026,
  author = {Ahmed, Afsar U},
  title = {Decoding resistance in triple-negative breast cancer: NF-κB as a therapeutic target for oncolytic virotherapy},
  journal = {Molecular Therapy},
  year = {2026},
  volume = {34},
  number = {8},
  pages = {4372--4373},
  doi = {10.1016/j.ymthe.2026.07.007}
}
Kostenlos starten →